Li Ou 2025. TNFRSF1B-DRIVEN MYELOID PLASTICITY CONSTITUTES A CLINICALLY TRACTABLE IMMUNOSUPPRESSIVE AXIS ACROSS HUMAN CANCERS. LIFE: International Journal of Health and Life-Sciences. (Nov. 2025), 65–66. DOI:https://doi.org/10.20319/icrlsh.2025.6566.